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Background: The purpose of this study was to determine whether the National Institutes of 
Health Stroke Scale (NIHSS) score was associated with inhospital neurological and medical 
complications (NMC) in patients with posterior circulation infarction.
Methods: This retrospective study included all patients admitted to our stroke unit during a 
one-year period (n = 289). NMC included neurological deterioration (ie, worsening by 4 points 
or more of the NIHSS score during the hospital stay) and all other medical complications based 
on what was recorded in the patients’ charts.
Results: Seventy-nine patients (27%) experienced NMC. In posterior circulation infarction 
patients (n = 90), patients with NMC had a higher baseline NIHSS score (10.9 versus 2.2, 
P = 0.004) and a baseline NIHSS score .2 (78% versus 36%, P = 0.003). In stepwise logistic 
regression, an NIHSS score .2 (odds ratio: 8.2; 95% confidence interval: 1.64–41.0; P = 0.01) 
was associated with NMC. Similar results were observed for anterior circulation infarction 
patients but with a higher cutoff value for NIHSS score.
Conclusion: In ischemic stroke patients, an increased baseline NIHSS score was associated with 
an increased risk of NMC. This association applied to anterior-circulation as well as posterior 
circulation stroke, although zero on the NIHSS for posterior circulation stroke does not mean 
the absence of NMC during hospitalization. The clinical significance of these findings requires 
further evaluation in larger prospective studies.
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Introduction
During the acute phase of ischemic stroke, patients frequently experience neurological 
and medical complications (NMC). Post-stroke neurological event, so-called early 
neurological deterioration, is common, occurring in up to 40% of patients and is 
associated with a worse clinical outcome.1–3 Early neurological deterioration is caused 
by several pathophysiological mechanisms, including extension of infarction, hemor-
rhage, brain swelling (edema), seizure, and hydrocephalus. In addition, stroke patients 
can experience other medical events, such as urinary and chest infections, congestive 
heart failure, falls, pressure ulcer, gastrointestinal bleeding, deep venous thrombosis, 
and pulmonary embolism.2,4–6 These complications are a major cause of death during 
the acute and subacute phases of stroke.2 Despite scarce data to guide the management 
of these complications, it remains essential to predict these complications early in the 
course of ischemic stroke.
The National Institutes of Health Stroke Scale (NIHSS) is widely used as a stan-
dard instrument to evaluate the severity of a patient’s neurological deficit, both in the 
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emergency department and in the stroke unit.7 The NIHSS is 
a stroke-specific quantitative scale that examines the level of 
consciousness, language function, neglect, visual field, eye 
movements, facial palsy, motor strength, sensory   function, 
and coordination. The examination can be performed quickly, 
and the NIHSS score can be assessed by neurologists as 
well as non-neurologists after appropriate training.8,9 This 
scale shows excellent reliability and validity and has been 
used in most stroke trials in order to evaluate neurological 
outcome.10,11 Furthermore, evidence exists to show that the 
NIHSS is associated with final outcome after a stroke in 
terms of length of stay,12 survival, and discharge destination.13 
However, this scale is mainly weighted toward signs caused 
by anterior-circulation infarction.14 To date, it is still unclear 
whether baseline NIHSS score can also predict NMC in 
patients with posterior circulation infarction. The aim of this 
study was thus to determine whether baseline NIHSS score is 
associated with NMC, whatever the stroke localization.
Materials and methods
Study population
This retrospective study was carried out in the stroke unit 
at Amiens University Hospital and included all patients 
referred for an acute ischemic stroke during a one-year 
period. Patients with a transient ischemic attack (n = 42) or 
absence of a corresponding ischemic lesion (n = 12), poor 
initial prognosis (comatose or intubated patients; pulmonary 
infection at admission, n = 26), patients with onset of cerebral 
ischemic event more than 6 hours earlier (n = 30), and patients 
with multiple infarcts affecting both anterior and posterior cir-
culations (n = 5) were excluded. The remaining 289 patients 
were included. Cranial computed tomography and/or 
magnetic resonance imaging, 12-lead electrocardiography, 
cervical Doppler ultrasonography, transthoracic echocardiog-
raphy, and standard laboratory tests were performed in all 
patients on admission. Transesophageal echocardiography, 
specialized laboratory tests, and Holter electrocardiographic 
monitoring were performed in selected patients.
For each patient, clinical data were prospectively collected 
according to a standardized protocol,15 ie, age, gender, cause 
of ischemic stroke according to the TOAST (Trial of Org 
10172 in Acute Stroke Treatment) criteria16 (to which we 
added two well-known etiologies, ie, intracranial atheroscle-
rotic disease and aortic atherosclerotic disease) and stroke 
risk factors that had been previously identified or discovered 
during hospitalization, including hypertension (antihyper-
tensive treatment or systolic blood pressure .140 mmHg or 
diastolic blood pressure .90 mmHg prior to hospitalization), 
diabetes (insulin or oral antidiabetic therapy or fasting blood 
glucose .7 mmol/L on two occasions during   hospitalization), 
hypercholesterolemia (lipid lowering treatment or low-
density lipoprotein .1 g/L), coronary artery disease (defined 
as a known history of myocardial infarction or angina), 
current smoking, regular alcohol consumption (more than 
two alcoholic drinks daily), peripheral artery disease, and 
body mass index (kg/m2). Glomerular filtration rate was 
estimated using the four-component Modification of Diet in 
Renal Disease equation, which is based on age, gender, race, 
and serum creatinine concentration determined on admis-
sion. The presence of chronic kidney disease was defined 
as glomerular filtration rate ,60 mL/minute/1.73 m2, in 
accordance with the National Kidney Foundation   criteria.17 
Furthermore, treatment before hospitalization was also 
recorded. Severity of stroke was assessed using the NIHSS 
at hospital admission and then every 6 hours during the 
first 72 hours and once a day after the third day. All clinical 
physicians who recorded the NIHSS score were certified in 
administration of the scale, to improve intrareliability and 
inter-reliability. The present study received institutional 
review board approval (from the Commission d’Evaluation 
Ethique des Recherches Non Interventionnelles, Amiens 
University Hospital).
Definition of stroke localization
Diagnosis of stroke was based on clinical and radiological 
evaluation by a stroke fellow (MB) and a stroke attending 
physician (JMB) regardless of symptom duration. Anterior 
circulation infarction was defined as an acute focal neurologi-
cal deficit with at least two of the following three features: 
hemiparesis or hemisensory loss, and/or aphasia or other 
cortical dysfunction, and/or homonymous hemianopia, 
with a corresponding ischemic lesion on brain imaging. 
A diagnosis of posterior circulation infarction was based 
on hemiparesis or hemisensory loss and/or brainstem or 
cerebellar signs or isolated homonymous hemianopia, with 
corresponding ischemic lesion on brain imaging.18 Patients 
with lacunar syndromes, including pure motor stroke, pure 
sensory stroke, sensorimotor stroke, and ataxic hemiparesis, 
were diagnosed as anterior circulation infarction or posterior 
circulation infarction according to vascular imaging.19
Definition of NMC
During hospitalization, detailed data on NMC (including 
neurological and other medical events) were prospec-
tively recorded using a standardized form for each patient. 
A   neurological event was defined as worsening by 4 points 
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or more of the NIHSS score during the hospital stay. This 
clinical deterioration was systematically documented by 
instrumental examination (brain computed tomography 
scan and/or magnetic resonance imaging to determine the 
mechanism of this complication). For other medical events, 
the occurrence of infectious complications was recorded 
prospectively. The presence of other complications was based 
on what was recorded in the patients’ charts and according 
to clinical signs and diagnostic tests. Whenever needed, 
a   specialist consultation was used to confirm a diagnosis.
Statistical analysis
Clinical variables in patients with anterior circulation infarc-
tion and posterior-circulation infarction were first compared 
using Student’s t-tests for continuous variables and χ² tests 
for categorical variables. NIHSS score was analyzed both as 
a continuous variable and as a categorical variable. The best 
cutoff value was selected by building a receiver-operating 
characteristic curve using the Youden index. To compare 
patients with and without NMC, we then divided our 
population into two groups, ie, anterior circulation infarc-
tion and posterior circulation infarction. In each group, the 
same baseline variables were analyzed. Pertinent variables 
selected by univariate analysis with P , 0.1 were tested in a 
backward logistic regression analysis, and adjusted odd ratios 
(OR) and 95% confidence intervals (CI) were   generated. 
P   values ,0.05 were considered to be statistically   significant. 
All statistical analyses were performed using SPSS statistical 
software (SPSS Inc, Chicago, IL).
Results
Baseline variables
Amongst the 289 included patients, 199 (69%) had ante-
rior circulation infarction and 90 had posterior circulation 
  infarction. Demographic data and vascular risk factors did not 
differ between anterior circulation infarction and posterior 
circulation infarction patients, but baseline NIHSS scores 
did and were higher in anterior circulation infarction than 
in posterior circulation infarction (Table 1).
ME during hospitalization
Seventy-nine patients (27%) experienced 108 NMC (Table 2). 
Among the NMC, ischemic stroke recurrence was the most 
frequent neurological event, and pneumonia and urinary 
tract infection was the most frequent medical   complication. 
A tendency for higher frequency of NMC in patients with 
anterior circulation infarction than in patients with poste-
rior circulation infarction (31% versus 20%, P = 0.065) 
was observed. Using the receiver-operating characteristic 
curve analysis (Figure 1), the cutoff value of baseline NIHSS 
score predicting NMC was 5 for anterior circulation infarc-
tion (area under the curve = 0.797; 95% CI: 0.73–0.86; 
P , 0.001) and 2 for posterior circulation infarction (area 
under the curve = 0.799; 95% CI: 0.66–0.93; P , 0.001).
Patients with anterior circulation infarction
In 199 patients with anterior circulation infarction, smoking 
status (10% versus 25%, P = 0.02), hypercholesterolemia 
(18% versus 39%, P = 0.003), and body mass index $25 
(41% versus 56%, P = 0.047) were less frequent in patients 
with NMC, whereas a tendency was observed for higher 
frequency of chronic kidney disease in patients with NMC 
(34% versus 22%, P = 0.08). Patients with NMC had a higher 
NIHSS score (12.6 ± 8.3 versus 4.9 ± 5.0; P , 0.001) and 
baseline NIHSS score .5 (75% versus 22%, P , 0.001). 
Stepwise logistic regression selected the following inde-
pendent factors for NMC: NIHSS score .5 (OR: 6.3, 95% 
CI: 2.80–14.14; P , 0.001), smoking status (OR: 0.30, 95% 
CI: 0.10–0.85; P = 0.024), hypercholesterolemia (OR: 0.24, 
95% CI: 0.09–0.61; P = 0.003), and chronic kidney disease 
(OR: 3.4, 95% CI: 1.45–7.94; P = 0.005).
Table 1 Baseline variables by stroke localization (n = 289)
ACI 
(n = 199)
PCI 
(n = 90)
P value
Age (years) 68.0 ± 15.4 67.6 ± 14.7 0.83
Men 102 (51) 57 (63) 0.07
Previous main risk factors
Hypertension 118 (59) 63 (70) 0.09
Diabetes mellitus 52 (26) 23 (26) 1.00
Dyslipidemia 65 (33) 30 (33) 1.00
Active smoking 40 (20) 18 (20) 1.00
Coronary artery disease 
Atrial fibrillation
27 (14) 
39 (20)
13 (14) 
10 (11)
0.86 
0.09
PAD 21 (11) 12 (13) 0.55
Stroke 36 (18) 23 (26) 0.16
BMI $ 25 kg/m² 103 (52) 44 (49) 0.70
Alcohol consumption 30 (15) 12 (13) 0.86
Chronic kidney disease 52 (26) 26 (29) 0.67
Baseline NIHSS
NIHSS score 7.3 ± 7.1 4.0 ± 6.3 ,0.001
Causes of ischemic stroke
Large vessel atherosclerosis 29 (15) 11 (12) 0.71
Cardioembolic 76 (38) 24 (27) 0.06
Lacunar 19 (10) 10 (11) 0.68
Undetermined 
Other
63 (32) 
14 (7)
34 (38) 
7 (8)
0.35 
0.81
Notes: Results are presented either as means ± standard deviation (age and NIHSS 
score) or as n (%).
Abbreviations:  ACI,  anterior  circulation  infarction;  PCI,  posterior  circulation 
infarction; CAD, coronary artery disease; PAD, peripheral artery disease; BMI, body 
mass index; NIHSS, National Institutes of Health Stroke Scale.
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Patients with posterior circulation 
infarction
In the 90 patients with posterior circulation infarction, demo-
graphic data, and vascular risk factors were not statistically 
different according to the presence of NMC (Table 3). Patients 
with NMC had a higher baseline NIHSS score and more fre-
quently baseline NIHSS score .2, large vessel   atherosclerosis, 
and less frequently stroke with   undetermined etiology. 
Stepwise logistic regression selected the following indepen-
dent factors for NMC: NIHSS score .2 (OR: 8.2, 95% CI: 
1.64–41.0; P = 0.01), large vessel atherosclerosis (OR: 18.3, 
95% CI: 2.70–124.71; P = 0.003) and stroke of undetermined 
etiology (OR: 0.11, 95% CI: 0.01–0.97; P = 0.047).
When considering only patients who experienced neuro-
logical events (n = 10), similar results were observed: these 
patients had a higher baseline NIHSS score .2 (100% versus 
37%, P , 0.001), more frequently large vessel atherosclerosis 
(50% versus 7%, P = 0.002), and less frequently stroke with 
undetermined etiology (0% versus 42%, P = 0.012). When 
considering only patients who experienced medical events 
(n = 13), they had more frequently large vessel atherosclerosis 
(31% versus 9%, P = 0.05) and less frequently stroke with 
undetermined etiology (8% versus 43%, P = 0.015), whereas 
there was a tendency for higher baseline NIHSS score .2 
(69% versus 40%, P = 0.071).
Patients with baseline NIHSS score of 0
The 40 patients with posterior circulation infarction more 
frequently had a baseline NIHSS score of 0 than did patients 
with anterior circulation infarction (20% versus 11%, 
P = 0.001); two posterior circulation infarction patients 
experienced NMC, whereas no NMC occurred in anterior 
circulation infarction patients in this population.
Discussion
The present study showed that an increased baseline NIHSS 
score in ischemic stroke patients was associated with an 
increased risk of NMC. This association applied to anterior 
circulation as well as posterior circulation stroke, although 
the cutoff value for the baseline NIHSS score predicting 
NMC was different between anterior circulation infarction 
and posterior circulation infarction patients. Indeed, despite 
a higher baseline NIHSS score in anterior circulation infarc-
tion patients than in posterior circulation infarction patients, 
the NIHSS score on admission can predict NMC, both in 
anterior circulation infarction and posterior circulation infarc-
tion patients, with a 6–8-fold increase in risk. Our findings 
suggest that NIHSS assessment may be a useful approach to 
predict all NMC, even in patients with posterior circulation 
infarction, because it can alert the physician to the anticipated 
risk of NMC in an individual patient and can thus affect early 
decisions about further surveillance and diagnostics.
We showed that stroke patients experienced neurological 
and medical events in similar proportion. Our rate of compli-
cations is low compared with previous studies. Indeed, the 
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Figure 1 Receiver-operating characteristic curve analysis of National Institutes of 
Health Stroke Scale scores in patients with neurological and medical complications 
according to the type of ischemic stroke.
Table  2  NMC  observed  in  stroke  patients  (108  NMC  were 
observed in 79 patients)
Cases (n)
Neurological event 48
Ischemic stroke recurrence 15
Symptomatic intracranial hemorrhage 14
Seizure 14
Malignant cerebral infarction 5
Medical event 60
Post-stroke infections 44
Nosocomial pneumonia 30
Urinary tract infection 12
Acute cholecystitis 1
Septic shock 1
Other causes 12
Acute renal failure 5
Severe hematuria 1
Peripheral arterial embolism 1
Aortic dissection 1
Mesenteric ischemia 1
Symptomatic bradycardia 1
Gastrointestinal bleeding 1
Acute pulmonary edema 1
Abbreviation: NMC, neurological and medical complications.
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first studies which focused on NMC after stroke reported 
frequencies up to 90%.6,20–22 More recently, the complication 
rate decreased, and it was estimated to be around 25%.2,23,24 
One explanation could be the better care of patients in stroke 
units,25 because improvement in outcome has been largely 
attributed to more effective prevention and treatment of 
NMC arising during stroke recovery. On the other hand, 
the heterogeneity of these results may be partly explained 
by the differences in study designs, criteria used for iden-
tifying complications, and also variations in identification 
and recording of complications. Chest infection is known 
to be one of the most frequent medical complications of 
stroke.4,21 Several investigations have studied demographic 
data and conventional risk factors associated with the risk 
of pneumonia in patients with stroke, and reported age older 
than 65 years, impaired consciousness, speech impairment, 
dysphagia, cognitive impairment, and brainstem strokes to be 
associated with development of chest infections.26–28 Urinary 
tract infections are also a frequent occurrence in patients with 
acute stroke.21,23 Similarly, increased age and stroke severity 
are independent predictors of urinary tract infections.29,30 The 
association of pneumonia with baseline NIHSS has been 
reported previously,30,31 but no cutoff value was determined. 
Recently, Chumbler et al found that NIHSS score at admis-
sion, associated with several other clinical variables, can 
identify stroke patients at higher risk of pneumonia.32
The NIHSS is increasingly being used as a measure 
of stroke severity among patients with ischemic stroke. 
  However, previous studies have mainly included patients 
with anterior circulation infarction, with volumes of infarct 
lesions correlating well with NIHSS,33 whereas lesion vol-
umes do not correlate with NIHSS score in patients with 
posterior circulation infarction.34 We found that NIHSS 
score was significantly associated with NMC in patients with 
posterior circulation infarction, albeit with a lower cutoff 
point than anterior circulation infarction. Despite posterior 
circulation infarction representing a heterogeneous group of 
strokes with various clinical presentations which cannot be 
captured as deficits on the NIHSS, our findings underscore 
the importance of using the NIHSS not only as a measure 
of stroke severity, but also as part of the assessment of risk 
of NMC. This may have some practical clinical implications 
to redirect preventive strategies in patients at risk because it 
can alert the physician to the anticipated risk of NMC in an 
individual patient. However, we also showed that patients with 
posterior circulation infarction (but not those with anterior 
circulation infarction) who had a baseline NIHSS score of 0 
could experience NMC. Similar results have been reported 
by Sato et al to determine the cutoff baseline NIHSS score 
that predicts long-term outcome in anterior circulation versus 
posterior circulation ischemic strokes.35 This finding indicates 
that NIHSS score alone cannot be used to rule out the risk 
of NMC in posterior circulation infarction patients and that 
the NIHSS does not substitute for further surveillance and 
diagnostics.
We also found that medical events were significantly 
more frequent in patients with large vessel atherosclerosis 
and significantly less frequent in patients with stroke of 
“undetermined”   etiology. It is well known that stroke 
patients suffering from large vessel atherosclerosis have a 
higher risk of morbidity from other clinical manifestations 
Table 3 Demographic and clinical characteristics of patients with 
posterior circulation infarction (n = 90) according to the presence 
or absence of NMC
All patients 
(n = 90)
NMC 
(n = 18)
No NMC 
(n = 72)
P value
Age (years) 67.6 ± 14.7 72.0 ± 9.8 66.6 ± 15.9 0.16
Men 57 (63) 10 (56) 47 (65) 0.58
Previous main risk factors
Hypertension 63 (70) 12 (67) 51 (71) 0.78
Diabetes mellitus 23 (26) 7 (39) 16 (22) 0.22
Dyslipidemia 30 (33) 7 (39) 23 (32) 0.59
Active smoking 18 (20) 3 (17) 15 (21) 1.00
CAD 13 (14) 1 (6) 12 (17) 0.45
PAD 12 (13) 2 (11) 10 (14) 1.00
Stroke 23 (26) 7 (39) 16 (22) 0.22
BMI . 25 kg/m² 44 (49) 8 (44) 36 (50) 0.79
Alcohol consump-
tion
12 (13) 2 (11) 10 (14) 1.00
Chronic kidney  
disease
26 (29) 4 (22) 22 (31) 0.57
Baseline NIHSS
NIHSS score 4.0 ± 6.3 10.9 ± 11.0 2.2 ± 2.4 0.004
NIHSS score .2 40 (44) 14 (78) 26 (36) 0.003
Causes of ischemic stroke
Large vessel  
atherosclerosis  
Cardioembolic 
Lacunar 
Undetermined 
Other
11 (12) 
 
24 (27) 
10 (11) 
34 (38) 
7 (8)
7 (39) 
 
6 (33) 
2 (11) 
1 (6) 
2 (11)
4 (6) 
 
18 (25) 
8 (11) 
33 (46) 
5 (7)
0.001 
 
0.55 
1.00 
0.001 
0.6
Therapeutics before hospitalization
Antihypertensive  
therapy
60 (67) 12 (67) 46 (64) 1.00
Antiplatelet  
agents
35 (39) 6 (33) 29 (40) 0.79
Anticoagulants 4 (4) 2 (11) 2 (3) 0.18
Statins 24 (27) 3 (17) 21 (29) 0.38
Note: Results are presented either as the mean ± standard deviation (age and 
NIHSS score) or as n (%).
Abbreviations: CAD, coronary artery disease; PAD, peripheral artery disease; BMI, 
body mass index; NIHSS, National Institutes of Health Stroke Scale; NMC, neurological 
and medical complications.
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of atherosclerotic disease, such as myocardial infarction, 
angina, peripheral artery disease, and vascular death.36,37 
Furthermore, the presence of large vessel atherosclerosis 
reflects inflammation, and there is evidence to suggest 
that systemic inflammation is predictive of poor outcome 
after stroke. For example, Whiteley et al showed that the 
C-reactive protein level was associated with both vascular 
and nonvascular deaths after stroke, independently of initial 
stroke severity.38
This study has several potential limitations. First, baseline 
NIHSS scoring was not performed in the emergency department 
but in our stroke unit. This may have biased our results, because 
patients could deteriorate during transfer from the emergency 
department to the stroke unit, although patients with a history 
of an acute ischemic cerebral event more than 6 hours earlier 
were excluded from the study. Furthermore, our data were 
obtained from a single academic hospital setting and therefore 
may not be generalizable to other settings. Our results are also 
obtained from a retrospective analysis in a small sample size, 
and therefore prospective validation is required before NIHSS 
score can be considered as a   predictor of NMC.
In conclusion, despite some methodological limitations, 
the present study shows that, in ischemic stroke patients, 
baseline NIHSS score is associated with an increased risk 
of NMC during hospitalization. This association between 
baseline NIHSS and NMC applies to anterior circulation 
as well as posterior circulation strokes, although NIHSS 
appears to have limitations in the latter, because zero on the 
NIHSS does not equal the absence of NMC. The clinical 
significance of these findings requires further evaluation in 
larger prospective studies.
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